abstract |
The present invention relates to substituted derivatives of quinoxaline and pyridopyrazine of formula (I), wherein the variables are as defined in the claims. The compounds of the present invention are useful as inhibitors of pI3Kβ. In addition, the present invention relates to pharmaceutical compositions containing these compounds as an active ingredient, as well as the use of these compounds as a medicine. |